InsiderTrades

Form 4 for APVO Aptevo Therapeutics Inc.

Accepted 2024-03-05 00:00:00 ET · period of report 2024-03-02 · accession 0000950170-24-025921 · SEC index · Original document

Summary rows

Aggregated the way they appear in lists: one row per insider, transaction code and security table.

X Filed Traded Ticker Insider Title Type Price Qty Owned ΔOwn Value
DM 2024-03-05 2024-03-02+ APVO Taylor Daphne SVP, CFO M - OptEx — +5,251 18.4K +40% —
DM 2024-03-05 2024-03-02+ APVO Taylor Daphne SVP, CFO M - OptEx $0.00 -5,251 7,333 -42% $0

Purchase Sale Sale after option exercise All abbreviations

Every reported transaction

#TableSecurityDateCodeA/DSharesPriceOwned afterOwnExercise / expiryUnderlyingFootnotes
1 Common Common Stock 2024-03-02 M A 3,667 — 16,827 D — — (F1) Restricted Stock Units ("RSUs") convert into common stock, $0.001 par value per share, of the Issuer on a one-for-one basis.
2 Common Common Stock 2024-03-04 M A 1,584 — 18,411 D — — (F1) Restricted Stock Units ("RSUs") convert into common stock, $0.001 par value per share, of the Issuer on a one-for-one basis.
3 Derivative Restricted Stock Unit 2024-03-04 M D 1,584 $0.00 1,583 D — · — to — 1,584 Common Stock (F1) Restricted Stock Units ("RSUs") convert into common stock, $0.001 par value per share, of the Issuer on a one-for-one basis. (F3) On June 7, 2022, the reporting person was granted 4,750 RSUs, vesting in three approximately equal annual installments beginning on March 4, 2023.
4 Derivative Restricted Stock Unit 2024-03-02 M D 3,667 $0.00 7,333 D — · — to — 3,667 Common Stock (F1) Restricted Stock Units ("RSUs") convert into common stock, $0.001 par value per share, of the Issuer on a one-for-one basis. (F2) On March 3, 2023, the reporting person was granted 11,000 RSUs, vesting in three approximately equal annual installments beginning on March 2, 2024.